Dr. Peter Metrakos

Dr. Peter Metrakos is the Program Leader of the Cancer Research Program and a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC).

A Professor in the Department of Surgery at McGill University’s Faculty of Medicine and Health Sciences, Dr. Metrakos also heads the MUHC’s high-volume hepatopancreatobiliary and transplant surgery service. His research has already changed the paradigm of care for colorectal cancer liver metastases. Under his leadership, the MUHC’s Cancer Research Program has grown into the largest adult cancer research group in Quebec. From the collaborative efforts of top oncologists and cancer researchers at the MUHC, a range of personalized, precision cancer treatments are coming to the fore. This could lead to new ways to diagnose and treat cancers, from ovarian and breast to liver cancer.

Already, the MUHC’s Cancer Research Program is harnessing the power of two promising new methods of cancer detection: liquid biopsy, or using a patient’s blood to detect cancer cells, and organoids, patient tumours grown in a lab that will allow treatments to be tested before administering them to a patient. Both are on the cusp of being a standard of cancer care and will ensure patients can receive the optimal treatment right away.

In honour of the dedication of Dr. Metrakos to advance precision cancer medicine, all proceeds from Le Bal Rouge 2024 will support the RI-MUHC Cancer Research Program through the MUHC Foundation’s $35 million Dream Big. End Cancer campaign.